Impact of Pregnancy on Maternal Pharmacokinetics of Medications
Author:
- Mary F. HebertMHMary F. Hebert
- 1 January 2013
- book chapter
- Published by Elsevier
- p. 17-39
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- CYP2D6 Mediates 4-Hydroxylation of Clonidine In Vitro: Implication for Pregnancy-Induced Changes in Clonidine ClearanceDrug Metabolism and Disposition, 2010
- Pharmacokinetics of Metformin during PregnancyDrug Metabolism and Disposition, 2010
- Glucuronidation of Dihydrotestosterone and trans-Androsterone by Recombinant UDP-Glucuronosyltransferase (UGT) 1A4: Evidence for Multiple UGT1A4 Aglycone Binding SitesDrug Metabolism and Disposition, 2010
- Lopinavir protein binding in HIV‐1‐infected pregnant womenHIV Medicine, 2010
- Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metforminPharmacogenetics and Genomics, 2009
- Clonidine Pharmacokinetics in PregnancyDrug Metabolism and Disposition, 2009
- Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical PracticeClinical Pharmacology & Therapeutics, 2009
- Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human IntestineDrug Metabolism and Disposition, 2007
- Pharmacokinetics and Safety of Indinavir in Human Immunodeficiency Virus-Infected Pregnant WomenAntimicrobial Agents and Chemotherapy, 2007
- Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant womenBritish Journal of Clinical Pharmacology, 2006